Peptide Technologies Inc (PEPT) financial statements (2021 and earlier)

Company profile

Business Address 5348 VEGAS DRIVE #177
LAS VEGAS, NV 89108
State of Incorp. NV
Fiscal Year End March 31
SIC 2844 - Perfumes, Cosmetics, and Other Toilet Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
11/30/2014
11/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2589210
Cash and cash equivalents2589210
Inventory, net of allowances, customer advances and progress billings248247   
Inventory248247    
Prepaid expense  9   
Other undisclosed current assets     51
Total current assets:250252982151
Noncurrent Assets
Intangible assets, net (including goodwill)378133
Intangible assets, net (excluding goodwill)378133 
Other noncurrent assets    3 
Other undisclosed noncurrent assets     (51)
Total noncurrent assets:378135(51)
Other undisclosed assets    (3) 
TOTAL ASSETS:2532591061540
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:344318274269689 
Accounts payable5951383837 
Accrued liabilities6545151042 
Employee-related liabilities221221221221580 
Other undisclosed accounts payable and accrued liabilities    30 
Debt20970    
Due to related parties13113113167  
Total current liabilities:685519405336689 
Noncurrent Liabilities
Other undisclosed noncurrent liabilities11822270   
Total noncurrent liabilities:11822270   
Other undisclosed liabilities    1101,751
Total liabilities:8037404753367991,751
Stockholders' equity
Stockholders' equity attributable to parent, including:(551)(481)(370)(321)(795)(1,700)
Common stock127127127127156 
Additional paid in capital777777777732188148
Accumulated deficit(1,455)(1,385)(1,274)(1,180)(106)(106)
Other undisclosed stockholders' equity attributable to parent    (1,034)(1,743)
Total stockholders' equity:(551)(481)(370)(321)(795)(1,700)
TOTAL LIABILITIES AND EQUITY:25325910615451

Income statement (P&L) ($ in thousands)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
11/30/2014
11/30/2013
Revenues13  0 
Financial services revenue 0 
Cost of revenue(2)(2)    
Gross profit:(1)1  0 
Operating expenses(57)(78)92(49)(25)(34)
Other undisclosed operating loss  (183)   
Operating loss:(58)(77)(92)(49)(25)(34)
Nonoperating income (expense)(70)(35)(1)(0)6 
Foreign currency transaction gain (loss), before tax(2)(6)(1)(0)6 
Interest and debt expense(78)(29)1 (4)4
Loss from continuing operations before equity method investments, income taxes:(205)(140)(92)(50)(22)(29)
Other undisclosed loss from continuing operations before income taxes    (445) 
Loss before gain (loss) on sale of properties:(205)(140)(92)(50)(468)(29)
Other undisclosed net income196252186991,328 
Net income (loss):(9)1129450860(29)
Other undisclosed net loss attributable to parent(100)(223)(187)(99)  
Net income (loss) available to common stockholders, diluted:(110)(112)(94)(50)860(29)

Comprehensive Income ($ in thousands)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
11/30/2014
11/30/2013
Net income (loss):(9)1129450860(29)
Comprehensive income (loss), net of tax, attributable to parent:(9)1129450860(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: